China Diabetes Market Report: Patients, Prevalence, Oral Antidiabetics, Insulin and Diagnostics



China currently has the highest number of diabetics in the world. The disease has presently reached epidemic proportions in the adult population. Around three decades ago, less than one percent of the Chinese adult population had diabetes. These levels, however, have increased to around 12 percent - making it the diabetes capital of the world.

The rise of diabetes in China can be attributed to a number of factors. Driven by a strong economic growth over the past few decades, the Chinese population has become richer, fatter and less mobile. Apart from urbanisation and sedentary lifestyles, Chinese people are also genetically more vulnerable to diabetes compared to Europeans and many other population groups. Other factors such as poor awareness of health issues, high consumption of white rice, poor healthcare infrastructure, etc. have also driven the prevalence of the disease.

China’s diabetes statistics may ring alarm bells for the government and healthcare authorities, for drug and diagnostic manufacturers, however, it represents a goldmine. Fuelled by a continuous increase in healthcare expenditures, the market for diabetes drugs and diagnostics is expanding robustly in the country. This is creating lucrative opportunities for global healthcare companies at a time when growth rates in the more developed markets have declined.

IMARC’s new report “China Diabetes Market Report: Patients, Prevalence, Oral Antidiabetics, Insulin and Diagnostics” provides an analytical and statistical insight into the Chinese diabetes market. The report provides both current and future trends in the prevalence, demographical breakup, diagnosis and treatment of diabetes in China. The research study serves as an exceptional tool to understand the epidemiology, market trends, therapeutic structure, competitive structure and the outlook of the Chinese diabetes market. This report can serve as an excellent guide for investors, researchers, consultants, marketing strategists and all those who are planning to foray into the China diabetes market in any form.


What we have achieved in this report:

Comprehensive situation analysis of the Chinese diabetes epidemiology and its dynamics:

Focus of the Analysis:

  • Historical, current and future prevalence of diabetes in China
  • Historical, current and future prevalence of type-1 and type-2 diabetes in China
  • Historical, current and future prevalence of diabetes in the urban and rural regions in China
  • Historical, current and future prevalence of diabetes among males and females in China
  • Historical, current and future prevalence of diabetes among various age groups in China
  • Historical, current and future diagnosis rates for diabetes in China
  • Historical, current and future drug treatment rates for diabetes in China

 

Comprehensive situation analysis of the Chinese Oral Antidiabetics market and its dynamics:

Focus of the Analysis:

  • Performance of the Oral Antidiabetics market in China
  • Performance of key classes
  • Performance of key players
  • Market outlook

 

Comprehensive situation analysis of the Chinese Insulin market and its dynamics:

Focus of the Analysis:

  • Performance of the Insulin market in China
  • Performance of key classes
  • Performance of key players
  • Market outlook

 

Comprehensive situation analysis of the Chinese diabetes diagnostics market and its dynamics:

Focus of the Analysis:

  • Performance of the diabetes diagnostics market in China
  • Market Segmentation
  • Key players
  • Market outlook                              

1 Research Methodology
2 Executive Summary
3 Diabetes Disease Overview
    3.1 What is Diabetes?
    3.2 Diabetes Diagnosis and Treatment
        3.2.1 Diagnosis
        3.2.2 Treatment
    3.3 Diabetes Complications
4 Key Factors Driving the Diabetes Market in China
5 China Diabetes Epidemiology
    5.1 Diabetes Population and Prevalence Rates
    5.2 Population and Prevalence Rates by Diabetes Type (Type-1 and Type-2)
    5.3 Population and Prevalence Rates by Region
    5.4 Population and Prevalence Rates by Gender
    5.5 Population and Prevalence Rates by Age Group
    5.6 Diabetes Diagnosis and Drug Treatment Rates
6 China Diabetes Market
    6.1 Historical Market Trends (2008-2015)
    6.2 Market Breakup by Segment (2008-2015)
    6.3 China Oral Antidiabetics Market
        6.3.1 Historical Market Trends (2008-2015)
        6.3.2 Market Breakup by Class (2008-2015)
        6.3.3 Market Shares of Key Players
        6.3.4 Market Outlook (2016-2021)
    6.4 China Insulin Market
        6.4.1 Historical Market Trends (2016-2021)
        6.4.2 Market Breakup by Class
        6.4.3 Market Shares of Key Players
        6.4.4 Market Outlook (2016-2021)
    6.5 Market Outlook (2016-2021)
7 China Diabetes Diagnostics Market
    7.1 Historical Market Trends (2008-2015)
    7.2 Market Segmentation
    7.3 Key Players
    7.4 Market Outlook (2016-2021)

 

List of Figures

Figure 3 1: The Impact of Diabetes on the Human Body
Figure 3 2: Diabetes Complications
Figure 4 1: China: Overweight & Obese Population (in Millions), 2008, 2015 & 2021
Figure 4 2: Body Mass Index and Relative Risk of Type-2 Diabetes
Figure 4 3: Global: Breakup of Diabetes Patients by Region (in %), 2015 & 2031
Figure 5 1: China: Total Number of Diabetes Patients (in Millions), 2008- 2015
Figure 5 2: China: Total Number of Diabetes Patients (in Millions), 2016 – 2021
Figure 5 3: China (Type1 & Type2): Total Number of Diabetes Patients (in Millions), 2008- 2015
Figure 5 4: China (Type1 & Type2): Total Number of Diabetes Patients (in Millions) 2016 – 2021
Figure 5 5: China (Urban & Rural): Total Number of Diabetes Patients (in Millions), 2008- 2015
Figure 5 6: China  (Urban & Rural): Total Number of Diabetes Patients (in Millions), 2016 – 2021
Figure 5 7: China (Male & Female): Total Number of Diabetes Patients (in Millions), 2008- 2015
Figure 5 8: China (Male & Female): Total Number of Diabetes Patients (in Millions), 2016 – 2021
Figure 5 9: China: Total Number of Diabetes Patients by Age Group (20-39), (40-59) & (60-79) (in Millions), 2008- 2015
Figure 5 10: China: Total Number of Diabetes Patients by Age Group (20-39), (40-59) & (60-79) (in Millions), 2016 – 2021
Figure 5 11: China: Total Diagnosed & Drug Treated Diabetes Population (in Millions), 2008- 2015
Figure 5 12:China: Total Diagnosed & Drug Treated Diabetes Population (in Millions), 2016 – 2021
Figure 6 1: China: Diabetes Market (in Million US$), 2008-2015
Figure 6 2: China: Diabetes Market: Share of Oral Antidiabetics and Insulin (in %), 2008-2015
Figure 6 3: China: Oral Antidiabetics Market (in Million US$), 2008-2015
Figure 6 4: China: Oral Antidiabetics Market: Sales Share of Key Classes (in %), 2008-2015
Figure 6 5: China: Oral Antidiabetics Market: Sales Share of Key Players (in %)
Figure 6 6: China: Oral Antidiabetics Market Forecast (in Million US$), 2016-2021
Figure 6 7: China: Oral Antidiabetics Market Forecast: Sales Share of Key Classes (in %), 2015 & 2020
Figure 6 8: China: Insulin Market (in Million US$), 2008-2015
Figure 6 9: China: Insulin Market: Sales Share of Key Classes (in %), 2015
Figure 6 10: China: Insulin Market: Sales Share of Key Players (in %)
Figure 6 11: China: Insulin Market Forecast (in Million US$), 2016-2021
Figure 6 12: China: Insulin Market Forecast: Sales Share of Key Classes (in %), 2016 & 2021
Figure 6 13: China: Diabetes Market Forecast (in Million US$), 2016-2021
Figure 6 14: China: Diabetes Market Forecast: Share of Oral Antidiabetics and Insulin (in %), 2015-2020
Figure 7 1: China: Diabetes Diagnostics Market (in Million US$), 2008-2015
Figure 7 2: China: Diabetes Diagnostics Market Forecast (in Million US$), 2016-2021

 

List of Tables

Table 2 1: China: Diabetes Epidemiology: Executive Summary
Table 2 2: China: Diabetes Market: Executive Summary
Table 3 1: Diagnosis of Diabetes
Table 4 1: China: Overweight & Obesity Statistics, 2007, 2011 & 2015
Table 4 2: China: Urban & Rural Population Breakup (in Millions), 1992, 2002, 2012 & 2015
Table 4 3: Global: Diabetes Population Breakup by Country (in 000’s), 2015 & 2021
Table 4 4: Global: Market Size & Growth Rates of Top Emerging and Developed Diabetes Drug Markets
Table 5 1: China: Total Prevalence & Number of Diabetes Patients, 2008, 2015 & 2021
Table 5 2: China (Type1 & Type2): Total Prevalence & Number of Diabetes Patients, 2008, 2015 & 2021
Table 5 3: China (Urban & Rural): Total Prevalence & Number of Diabetes Patients, 2008, 2015 & 2021
Table 5 4: China (Male & Female): Total Prevalence & Number of Diabetes Patients, 2008, 2015 & 2021
Table 5 5: Total Prevalence & Number of Diabetes Patients by Age Group (20-39), (40-59) & (60-79) (In Millions), 2008, 2015 & 2021
Table 5 6: China: Total Diagnosed & Drug Treated Diabetes Population, 2008, 2015 & 2021


Note: We value your privacy and will never rent or sell your email address. Privacy policy

Special Prices


    IMARC provides special pricing for:

  • Academic Institutes
  • Government Agencies
  • Nonprofit Organizations
  • For more information, feel free to contact us.






Related Report

Global Biopharmaceutical Manufacturing Market Report 2017-2021

IMARC Group’s latest report titled “Global Biopharmaceutical Manufacturing Market Report 2017-2021” provides a detailed analysis on the global biopharmaceutical manufacturing industry. Biopharmaceuticals represent one of the most elegant and sophisticated achievements of modern science. Compar...


Global Biopharmaceutical Market Report & Forecast (2017-2021)

IMARC’s new report “Global Biopharmaceutical Market Report & Forecast (2017-2021)” gives a deep insight into the global biopharmaceutical market. The research study serves as an analytical as well as a statistical tool to understand the strengths, weaknesses, opportunities, threats, market tre...


Global Portable Medical and Healthcare Devices Market Report (Cardiac Monitoring Devices, Blood Glucose Monitoring, Pulse Oximetry Devices, Wearable BP Monitors, Smart Wrist-Wearables, Smart Garments etc.) (2017-2021)

The health of a citizen directly affects the productivity and growth of a country’s economy. Therefore, the expenditure on maintaining a good health becomes indispensable. A study has revealed a considerable increment in the heart related problems worldwide which often requires treatment paired wi...


Canada Generic Drug Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2017-2022

The report entitled “Canada Generic Drug Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2017-2022” represents an in-depth analysis on the historical, current and future trends in the generic drug market in Canada. This research report serves as an exceptional tool to unde...


Japan Generic Drug Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2017-2022

The report entitled “Japan Generic Drug Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2017-2022” represents an in-depth analysis on the historical, current and future trends in the generic drug market in Japan. This research report serves as an exceptional tool to unders...